These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 17162235)
1. Cost-effectiveness of treating esophageal varices. Talwalkar JA Clin Liver Dis; 2006 Aug; 10(3):679-89, xi. PubMed ID: 17162235 [TBL] [Abstract][Full Text] [Related]
2. Costs and clinical outcomes of primary prophylaxis of variceal bleeding in patients with hepatic cirrhosis: a decision analytic model. Saab S; DeRosa V; Nieto J; Durazo F; Han S; Roth B Am J Gastroenterol; 2003 Apr; 98(4):763-70. PubMed ID: 12738453 [TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of preventing variceal hemorrhage. Post AB Hepatology; 2003 Aug; 38(2):534-5; author reply 535. PubMed ID: 12883502 [No Abstract] [Full Text] [Related]
4. Cost-effectiveness analysis of beta-blockers vs endoscopic surveillance in patients with cirrhosis and small varices. Di Pascoli L; Buja A; Bolognesi M; Montagnese S; Gatta A; Gregori D; Merkel C World J Gastroenterol; 2014 Aug; 20(30):10464-9. PubMed ID: 25132763 [TBL] [Abstract][Full Text] [Related]
5. Cost-effective therapeutic strategy for the management of bleeding gastric fundal varices. Matsumoto A; Takimoto K; Kuchide M; Yamauchi Y; Takemura T Endoscopy; 2004 Nov; 36(11):1031-2; author reply 1032-3. PubMed ID: 15520927 [No Abstract] [Full Text] [Related]
6. A commonsense approach to esophageal varices. Longacre AV; Garcia-Tsao G Clin Liver Dis; 2006 Aug; 10(3):613-25, x. PubMed ID: 17162231 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding. Imperiale TF; Klein RW; Chalasani N Hepatology; 2007 Apr; 45(4):870-8. PubMed ID: 17393528 [TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage. Targownik LE; Spiegel BM; Dulai GS; Karsan HA; Gralnek IM Am J Gastroenterol; 2004 Jul; 99(7):1306-15. PubMed ID: 15233670 [TBL] [Abstract][Full Text] [Related]
9. An evidence-based medicine approach to beta-blocker therapy in patients with cirrhosis. Talwalkar JA; Kamath PS Am J Med; 2004 Jun; 116(11):759-66. PubMed ID: 15144913 [TBL] [Abstract][Full Text] [Related]
11. The budget impact of endoscopic screening for esophageal varices in cirrhosis. Spiegel BM; Esrailian E; Eisen G Gastrointest Endosc; 2007 Oct; 66(4):679-92. PubMed ID: 17905009 [TBL] [Abstract][Full Text] [Related]
12. A balancing view: Should cirrhotic patients with small esophageal varices undergo primary bleeding prophylaxis? Carey W Am J Gastroenterol; 2009 Sep; 104(9):2136-8. PubMed ID: 19727080 [No Abstract] [Full Text] [Related]
13. Pharmacological versus endoscopic therapy in the prevention of variceal hemorrhage: and the winner is.. Bosch J; Garcia-Tsao G Hepatology; 2009 Sep; 50(3):674-7. PubMed ID: 19714716 [No Abstract] [Full Text] [Related]